National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Hepatobiliary Cancers Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Thomas A. Abrams, MD

None

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

8/6/2009

Edgar Ben-Josef, MD

None

None

None

None

9/30/2009

Al B. Benson III, MD

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

Abbott Laboratories;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Enzon Pharmaceuticals;
Genentech, Inc.;
General Electric;
Genomic Health, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

7/23/2009

P. Mark Bloomston, MD

None

None

None

None

7/1/2009

Jean F. Botha, MB, BCh

None

None

None

None

11/20/2009

Bryan M. Clary, MD

None

Covidien AG;
Onyx Pharmaceuticals, Inc.;
sanofi-aventis U.S.

None

None

11/20/2009

Anne M. Covey, MD

None

None

None

None

7/2/2009

Steven A Curley, MD

None

None

None

None

11/20/2009

Michael I. D'Angelica, MD

None

None

None

None

11/20/2009

William D. Ensminger, MD, PhD

None

None

None

None

7/6/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

John F. Gibbs, MD, FACS, MHCM

None

None

None

None

11/20/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Daniel Laheru, MD

None

Concordia Pharmaceuticals;
GenVEC

None

None

8/13/2009

Mokenge P. Malafa, MD, FACS

National Cancer Institute;
Davos Life Sciences, Singapore

None

Biogene, Singapore

None

11/20/2009

Jorge Marrero, MD, MS

Bayer HealthCare;
Bristol-Myers Squibb Company

Onyx Pharmaceuticals, Inc.

None

None

9/29/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Nicole McMillian, MS

None

None

None

None

7/21/2009

Steven G. Meranze, MD

None

None

None

None

7/1/2009

Susan Moench, PhD

None

None

None

None

7/1/2009

Sean J. Mulvihill, MD

National Cancer Institute

None

None

None

7/1/2009

James O. Park, MD

None

None

None

None

11/20/2009

James A. Posey, MD

Bayer HealthCare

Bayer HealthCare

None

None

11/19/2009

Jasgit Sachdev, MD

None

None

None

None

7/9/2009

Riad Salem, MD, MBA

MDS Nordion

MDS Nordion

None

None

11/20/2009

Elin R. Sigurdson, MD, PhD

None

sanofi-aventis U.S.

None

None

7/1/2009

Jean-Nicolas Vauthey, MD

None

None

None

None

7/1/2009

Alan P. Venook, MD

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

11/18/2009

Yun Yen, MD, PhD, FACP

None

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.

None

None

9/28/2009

Andrew X Zhu, MD, PhD

Bayer HealthCare;
Genentech, Inc.

Bayer HealthCare;
Genentech, Inc.

None

None

11/20/2009

 

NCCN Website Supporters